Advocacy intelligence hub — real-time data for patient organizations
Johns Hopkins Bloomberg School of Public Health — PHASE3
Al-Azhar University — PHASE2
Novartis Pharmaceuticals — PHASE2
Assiut University
University of Virginia
Vowst: FDA approved
to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI)
Alinia: FDA approved
Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Alinia
Romark Laboratories, L.C.
Alinia
(Nitazoxanide)Orphan drugRomark Laboratories, L.C.
AmBisome
(Liposomal amphotericin B)Orphan drugstandardFujisawa USA, Inc.
Lipid-based Polyene Antifungal [EPC]
Stefania Pane
Bambino Gesù Children's Hospital
Lorenza Putignani
Bambino Gesù Children's Hospital
Panagiotis Karanis
University of Cologne
Melissa S Love
a division of The Scripps Research Institute
Saumya Srivastava
All India Institute of Medical Sciences
Wesley C Van Voorhis
University of Washington